Dr Susan Catalano of Cognition Therapeutics talks the science behind the Icelandic Mutation and their potential upcoming drug for the treatment of Alzheimer disease.
Dr Catalano is the co-founder and chief science officer at Cognition Therapeutics.
2 Clarke Drive
Cranbury, NJ 08512